This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J&J Issues Tylenol Recalls

NEW YORK ( TheStreet) -- Johnson & Johnson's (JNJ - Get Report) McNeil Consumer Healthcare division is recalling certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products as a precautionary measure.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

J&J said the recall is part of a review of past production where instances of inefficient equipment cleaning was found.

J&J is also recalling certain lots of Benadryl, Sudafed and Sinutab products for the same reason, all at the wholesale level, and said this doesn't require action by consumers.

The products were distributed in the U.S., the Caribbean and Brazil and were made at the McNeil plant in Fort Washington, Pa before Apr. 2010, when production at the facility was suspended pending investigations over the unit's manufacturing practices and recalls.





McNeil said it's also recalling lots of Rolaids Multi-Symptom Berry Tablets, distributed in the U.S., in order to update the labeling. According to the company, the current labeling does not include the words, "does not meet USP." USP, or The United States Pharmacopeia, is a non-governmental testing method for medicines that is not required by FDA for the sale of medicines, J&J said.

Shares of J&J were falling 0.2% to $62.40 shortly after the market open Tuesday.

More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.



>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to: tips@thestreet.com.

RELATED STORIES:



Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
GSK $47.29 0.00%
JNJ $99.58 0.00%
SNN $34.12 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs